Evelo Biosciences, Inc.
EVLO · OTC
9/30/2023 | 6/30/2023 | 3/31/2023 | 12/31/2022 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$12,364 | -$21,103 | -$25,341 | -$23,541 |
| Dep. & Amort. | $169 | $424 | $445 | $523 |
| Deferred Tax | $0 | $1,642 | $0 | $0 |
| Stock-Based Comp. | $2,476 | $2,365 | $2,909 | $3,421 |
| Change in WC | -$3,494 | -$4,021 | $1,455 | -$5,726 |
| Other Non-Cash | $2,805 | $866 | $256 | $2,133 |
| Operating Cash Flow | -$10,408 | -$19,827 | -$20,276 | -$23,190 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$47 | $0 | -$12 | -$228 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $560 | -$12 | $0 | $0 |
| Investing Cash Flow | $513 | -$12 | -$12 | -$228 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | -$3,123 |
| Stock Issued | $24,305 | $0 | $0 | $4,862 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$5,085 | -$199 | -$199 | $0 |
| Financing Cash Flow | $19,220 | -$199 | -$199 | $1,739 |
| Forex Effect | -$49 | -$18 | $17 | $568 |
| Net Chg. in Cash | $9,276 | -$19,845 | -$20,470 | -$21,111 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $8,783 | $28,628 | $49,098 | $70,209 |
| End Cash | $18,059 | $8,783 | $28,628 | $49,098 |
| Free Cash Flow | -$10,455 | -$19,827 | -$20,288 | -$23,418 |